AAPL 235.01 0.2602% MSFT 417.195 0.0012% NVDA 133.69 0.3453% GOOGL 190.66 -0.1832% GOOG 192.02 -0.1404% AMZN 220.31 0.8468% META 599.19 -1.5025% AVGO 226.12 0.3684% TSLA 415.11 2.9258% TSM 203.74 1.182% LLY 734.475 -7.9005% V 308.565 0.536% JPM 245.29 0.4422% UNH 537.99 -0.5821% NVO 81.145 -4.1066% WMT 91.485 -0.0492% LVMUY 134.55 0.6508% XOM 108.8074 -0.4416% LVMHF 675.0 1.6499% MA 504.77 -0.0277%
Last update at 2025-01-14T16:59:00Z
Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals
Mon 23 Sep 24, 08:15 PMHigh Growth Tech Stocks To Watch In September 2024
Mon 02 Sep 24, 02:04 PMImplied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options
Thu 29 Aug 24, 12:30 PMACADIA Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
Thu 08 Aug 24, 11:31 AMAcadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues
Wed 07 Aug 24, 12:16 PMAcadia Pharmaceuticals (ACAD) Beats Q2 Earnings and Revenue Estimates
Tue 06 Aug 24, 09:45 PMAcadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
Tue 06 Aug 24, 08:05 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -213.44400M | -167.51900M | -280.97300M | -234.38300M | -243.93600M |
Minority interest | - | - | - | - | - |
Net income | -215.97500M | -167.87000M | -281.58400M | -235.25900M | -245.19200M |
Selling general administrative | 369.09M | 396.03M | 388.66M | 325.64M | 265.76M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 507.07M | 465.00M | 421.20M | 319.48M | 205.48M |
Reconciled depreciation | 2.03M | 3.34M | 2.93M | 2.77M | 3.00M |
Ebit | -225.62200M | -173.78300M | -289.51800M | -249.31100M | -250.44900M |
Ebitda | -223.59600M | -170.43900M | -286.58600M | -246.54500M | -247.44400M |
Depreciation and amortization | 2.03M | 3.34M | 2.93M | 2.77M | 3.00M |
Non operating income net other | - | -2.32900M | -0.99700M | 1.00M | -1.84000M |
Operating income | -223.59600M | -170.43900M | -286.58600M | -246.54500M | -247.44400M |
Other operating expenses | 740.83M | 654.58M | 728.34M | 585.62M | 471.25M |
Interest expense | 6.61M | 6.26M | 8.54M | 14.93M | 0.00000M |
Tax provision | 2.53M | 0.35M | 0.61M | 0.88M | 1.26M |
Interest income | 6.61M | 0.59M | 6.61M | 11.16M | 5.35M |
Net interest income | 6.61M | 0.59M | 6.61M | 11.16M | 5.35M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 2.53M | 0.35M | 0.61M | 0.88M | 1.26M |
Total revenue | 517.24M | 484.14M | 441.75M | 339.08M | 223.81M |
Total operating expenses | 730.66M | 635.44M | 707.79M | 566.02M | 452.92M |
Cost of revenue | 10.17M | 19.14M | 20.55M | 19.60M | 18.33M |
Total other income expense net | 10.15M | 2.92M | 5.61M | 12.16M | -1.84000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -215.97500M | -167.87000M | -281.58400M | -235.25900M | -245.19200M |
Net income applicable to common shares | -215.97500M | -167.87000M | -281.58400M | -235.25900M | -245.19200M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 748.96M | 587.81M | 700.12M | 782.62M | 783.18M |
Intangible assets | 65.49M | - | - | 1.11M | 2.58M |
Earning assets | - | - | - | - | - |
Other current assets | 39.09M | 21.40M | 23.89M | 25.69M | 18.61M |
Total liab | 317.20M | 187.40M | 159.23M | 155.61M | 84.05M |
Total stockholder equity | 431.75M | 400.41M | 540.89M | 627.01M | 699.13M |